Clinical trial
A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or…
NCT00183807 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00183807 |
|---|---|
| Title | A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer |
| Official title | A Phase II Study of Irinotecan (Camptosar), Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer |
| Lead sponsor | University of Southern California, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | irinotecan, cisplatin, celecoxib |
| Enrollment | 6 |
| Start date | Oct 1, 2003 |
| Primary completion | Feb 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: